Owens & Minor Inc. (NYSE: OMI) stock soared 6.68% to trade at $7.39 in Friday's pre-market session, following the company's better-than-expected fourth quarter 2024 earnings results and the announcement of a potential sale process for its Products & Healthcare Services segment.
The healthcare logistics company reported adjusted earnings per share of $0.55 for the fourth quarter, beating the consensus estimate of $0.52. Owens & Minor's revenue of $2.70 billion also topped analysts' expectations of $2.69 billion.
In the earnings release, Owens & Minor revealed that it is actively engaged in "robust discussions regarding the potential sale of its Products & Healthcare Services segment." The company stated that this move aligns with its strategy to focus on its higher-growth and higher-margin Patient Direct segment.
For the full year 2025, Owens & Minor expects revenue in the range of $10.85 billion to $11.15 billion, adjusted EBITDA between $560 million and $590 million, and adjusted EPS of $1.60 to $1.85. The company's guidance excludes any impact from the potential sale of the Products & Healthcare Services segment or the previously announced acquisition of Rotech.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。